• Published On : Jan-2018 |
  • Pages : 184 Pages |
  • Format :

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Clostridium Difficile Infection Treatment Market Opportunity Analysis 
     3.1. Macro-Economic Factors
     3.2. Drivers
     3.3. Restraints
     3.4. Opportunities
     3.5. Trends

4. North America Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     4.1. Introduction
     4.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            4.2.1. U.S.
            4.2.2. Canada
     4.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            4.3.1. U.S.
            4.3.2. Canada
     4.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            4.4.1. Metronidazole
            4.4.2. Vancomycin
            4.4.3. Fidaxomicin
     4.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            4.5.1. Metronidazole
            4.5.2. Vancomycin
            4.5.3. Fidaxomicin
     4.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            4.6.1. Oral
            4.6.2. Injectable
     4.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            4.7.1. Oral
            4.7.2. Injectable
     4.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            4.8.1. Hospital Pharmacies
            4.8.2. Retail Pharmacies
            4.8.3. Mail Order Pharmacies
     4.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            4.9.1. Hospital Pharmacies
            4.9.2. Retail Pharmacies
            4.9.3. Mail Order Pharmacies
     4.10.Drivers and Restraints: Impact Analysis
     4.11.Market Attractiveness Analysis
            4.11.1. By Country
            4.11.2. By Drug Type
            4.11.3. By Route of Administration
            4.11.4. By Distribution Channel
     4.12.Key Representative Market Participants
     4.13.Market Presence (Intensity Map)

5. Latin America Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     5.1. Introduction
     5.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            5.2.1. Brazil
            5.2.2. Mexico
            5.2.3. Rest of Latin America
     5.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            5.3.1. Brazil
            5.3.2. Mexico
            5.3.3. Rest of Latin America
     5.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            5.4.1. Metronidazole
            5.4.2. Vancomycin
            5.4.3. Fidaxomicin
     5.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            5.5.1. Metronidazole
            5.5.2. Vancomycin
            5.5.3. Fidaxomicin
     5.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            5.6.1. Oral
            5.6.2. Injectable
     5.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            5.7.1. Oral
            5.7.2. Injectable
     5.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            5.8.1. Hospital Pharmacies
            5.8.2. Retail Pharmacies
            5.8.3. Mail Order Pharmacies
     5.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            5.9.1. Hospital Pharmacies
            5.9.2. Retail Pharmacies
            5.9.3. Mail Order Pharmacies
     5.10.Drivers and Restraints: Impact Analysis
     5.11.Market Attractiveness Analysis
            5.11.1. By Country
            5.11.2. By Drug Type
            5.11.3. By Route of Administration
            5.11.4. By Distribution Channel
     5.12.Key Representative Market Participants
     5.13.Market Presence (Intensity Map)

6. Europe Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            6.2.1. Germany
            6.2.2. U.K.
            6.2.3. France
            6.2.4. Italy
            6.2.5. Spain
            6.2.6. Russia
            6.2.7. Rest of Europe
     6.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            6.3.1. Germany
            6.3.2. U.K.
            6.3.3. France
            6.3.4. Italy
            6.3.5. Spain
            6.3.6. Russia
            6.3.7. Rest of Europe
     6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            6.4.1. Metronidazole
            6.4.2. Vancomycin
            6.4.3. Fidaxomicin
     6.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            6.5.1. Metronidazole
            6.5.2. Vancomycin
            6.5.3. Fidaxomicin
     6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            6.6.1. Oral
            6.6.2. Injectable
     6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            6.7.1. Oral
            6.7.2. Injectable
     6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            6.8.1. Hospital Pharmacies
            6.8.2. Retail Pharmacies
            6.8.3. Mail Order Pharmacies
     6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            6.9.1. Hospital Pharmacies
            6.9.2. Retail Pharmacies
            6.9.3. Mail Order Pharmacies
     6.10.Drivers and Restraints: Impact Analysis
     6.11.Market Attractiveness Analysis
            6.11.1. By Country
            6.11.2. By Drug Type
            6.11.3. By Route of Administration
            6.11.4. By Distribution Channel
     6.12.Key Representative Market Participants
     6.13.Market Presence (Intensity Map)

7. Asia Pacific Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            7.2.1. China
            7.2.2. Japan
            7.2.3. India
            7.2.4. ASEAN
            7.2.5. Australia and New Zealand
            7.2.6. Rest of Asia Pacific
     7.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            7.3.1. China
            7.3.2. Japan
            7.3.3. India
            7.3.4. ASEAN
            7.3.5. Australia and New Zealand
            7.3.6. Rest of Asia Pacific
     7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            7.4.1. Metronidazole
            7.4.2. Vancomycin
            7.4.3. Fidaxomicin
     7.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            7.5.1. Metronidazole
            7.5.2. Vancomycin
            7.5.3. Fidaxomicin
     7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            7.6.1. Oral
            7.6.2. Injectable
     7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            7.7.1. Oral
            7.7.2. Injectable
     7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            7.8.1. Hospital Pharmacies
            7.8.2. Retail Pharmacies
            7.8.3. Mail Order Pharmacies
     7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            7.9.1. Hospital Pharmacies
            7.9.2. Retail Pharmacies
            7.9.3. Mail Order Pharmacies
     7.10.Drivers and Restraints: Impact Analysis
     7.11.Market Attractiveness Analysis
            7.11.1. By Country
            7.11.2. By Drug Type
            7.11.3. By Route of Administration
            7.11.4. By Distribution Channel
     7.12.Key Representative Market Participants
     7.13.Market Presence (Intensity Map)

8. Middle East & Africa Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            8.2.1. GCC Countries
            8.2.2. South Africa
            8.2.3. North Africa
            8.2.4. Rest of MEA
     8.3. Market Size (US$ Mn) Forecast By Country, 2017–2025
            8.3.1. GCC Countries
            8.3.2. South Africa
            8.3.3. North Africa
            8.3.4. Rest of MEA
     8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            8.4.1. Metronidazole
            8.4.2. Vancomycin
            8.4.3. Fidaxomicin
     8.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            8.5.1. Metronidazole
            8.5.2. Vancomycin
            8.5.3. Fidaxomicin
     8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            8.6.1. Oral
            8.6.2. Injectable
     8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            8.7.1. Oral
            8.7.2. Injectable
     8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            8.8.1. Hospital Pharmacies
            8.8.2. Retail Pharmacies
            8.8.3. Mail Order Pharmacies
     8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            8.9.1. Hospital Pharmacies
            8.9.2. Retail Pharmacies
            8.9.3. Mail Order Pharmacies
     8.10.Drivers and Restraints: Impact Analysis
     8.11.Market Attractiveness Analysis
            8.11.1. By Country
            8.11.2. By Drug Type
            8.11.3. By Route of Administration
8.11.4. By Distribution Channel
     8.12.Key Representative Market Participants
     8.13.Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Acronyms Used

12. Competition Landscape
     12.1.Competition Dashboard
     12.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
            12.2.1. Merck & Co., Inc.
            12.2.2. Baxter International Inc.
            12.2.3. Sanofi S.A.
            12.2.4. Pfizer Inc.
            12.2.5. Novartis AG
            12.2.6. Astellas Pharma
            12.2.7. Eli Lilly and Company
            12.2.8. AstraZeneca Plc.
            12.2.9. Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.)
            12.2.10. Mylan

13. Global Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region
     13.1.Introduction/Key Findings
     13.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
            13.2.1. North America
            13.2.2. Latin America
            13.2.3. Europe
            13.2.4. Asia Pacific
            13.2.5. Middle East & Africa
     13.3.Market Size (US$ Mn) Forecast By Region, 2017–2025
            13.3.1. North America
            13.3.2. Latin America
            13.3.3. Europe
            13.3.4. Asia Pacific
            13.3.5. Middle East & Africa
     13.4.Market Attractiveness Analysis By Region

14. Global Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Drug Type
     14.1.Introduction/Key Findings
     14.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2012–2016
            14.2.1. Metronidazole
            14.2.2. Vancomycin
            14.2.3. Fidaxomicin
     14.3.Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
            14.3.1. Metronidazole
            14.3.2. Vancomycin
            14.3.3. Fidaxomicin
     14.4.Market Attractiveness Analysis By Drug Type

15. Global Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Route of Administration
     15.1.Introduction/Key Findings
     15.2.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2012–2016
            15.2.1. Oral
            15.2.2. Injectable
     15.3.Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
            15.3.1. Oral
            15.3.2. Injectable
     15.4.Market Attractiveness Analysis By Route of Administration

16. Global Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
     16.1.Introduction/Key Findings
     16.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
            16.2.1. Hospital Pharmacies
            16.2.2. Retail Pharmacies
            16.2.3. Mail Order Pharmacies
     16.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
            16.3.1. Hospital Pharmacies
            16.3.2. Retail Pharmacies
            16.3.3. Mail Order Pharmacies
     16.4.Market Attractiveness Analysis By Distribution Channel

17. Global Clostridium Difficile Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
     17.1.Market Size and Y-o-Y Growth
     17.2.Absolute $ Opportunity

18. Research Methodology


List of Table

Table 01 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 02 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 03 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 04 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 05 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 06 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 07 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 08 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 09 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 10 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 11 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 12 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 13 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 14 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 15 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 16 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 17 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Country
Table 18 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Drug Type
Table 19 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Route of Administration
Table 20 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Distribution Channel
Table 21 : Global Clostridium Difficile Infection Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 22 : Global Clostridium Difficile Infection Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Drug Type
Table 23 : Global Clostridium Difficile Infection Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Route of Administration
Table 24 : Global Clostridium Difficile Infection Treatment Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Distribution Channel


List of Figure

Figure 01 : Global Clostridium Difficile Infection Treatment Market Shares, By Geography, 2017 (%)
Figure 02 : Global Clostridium Difficile Infection Treatment Market Shares, By Geography, 2025 (%)
Figure 03 : Global Clostridium Difficile Infection Treatment Market Value Share, By Drug Type (2017E)
Figure 04 : Global Clostridium Difficile Infection Treatment Market Value Share, By Route of Administration (2017E)
Figure 05 : Global Clostridium Difficile Infection Treatment Market Value Share, By Distribution Channel  (2017E)
Figure 06 : Global Burden of C. difficile Infection Treatment (2016)
Figure 07 : Antimicrobial Drugs (AD) Use in Acute Care Hospitals in the U.S.
Figure 08 : Incidence of C. difficile Infection Across Major Countries as Percentage of Total Hospital Admissions (2016)
Figure 09 : Trends in Origin of C. difficile Infection in Europe (2016)
Figure 10 : Trends in Healthcare Associated CDI in Europe (2016) 
Figure 11 : North America Clostridium Difficile Infection Treatment Market Value Share By Drug Type  (2017)
Figure 12 : North America Clostridium Difficile Infection Treatment Market Value Share By Route of Administration (2017)
Figure 13  : North America Clostridium Difficile Infection Treatment Market Value Share By Distribution Channel (2017)
Figure 14 : North America Clostridium Difficile Infection Treatment Market Value Share By Country  (2017)
Figure 15 : North America Clostridium Difficile Infection Treatment Market Forecast 2017 and 2025
Figure 16 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016
Figure 17 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 18 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Metronidazole
Figure 19 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Metronidazole
Figure 20 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Vancomycin
Figure 21 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Vancomycin
Figure 22 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Fidaxomicin 
Figure 23 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Fidaxomicin 
Figure 24 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Oral
Figure 25 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Oral
Figure 26 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Injectable
Figure 27 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Injectable
Figure 28 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Hospital Pharmacies
Figure 29 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Hospital Pharmacies
Figure 30 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Retail Pharmacies
Figure 31 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Retail Pharmacies
Figure 32 : North America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Mail Order Pharmacies
Figure 33 : North America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Mail Order Pharmacies
Figure 34 : North America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Drug Type
Figure 35 : North America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Route of Administration
Figure 36 : North America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Distribution Channel
Figure 37 : North America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Country
Figure 38 : Latin America Clostridium Difficile Infection Treatment Market Value Share By Drug Type  (2017)
Figure 39 : Latin America Clostridium Difficile Infection Treatment Market Value Share By Route of Administration (2017)
Figure 40 : Latin America Clostridium Difficile Infection Treatment Market Value Share By Distribution Channel (2017)
Figure 41 : Latin America Clostridium Difficile Infection Treatment Market Value Share By Country  (2017)
Figure 42 : Latin America Clostridium Difficile Infection Treatment Market Forecast 2017 and 2025
Figure 43 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016
Figure 44 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 45 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Metronidazole
Figure 46 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Metronidazole
Figure 47 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Vancomycin
Figure 48 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Vancomycin
Figure 49 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Fidaxomicin 
Figure 50 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Fidaxomicin 
Figure 51 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Oral
Figure 52 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Oral
Figure 53 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Injectable
Figure 54 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Injectable
Figure 55 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Hospital Pharmacies
Figure 56 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Hospital Pharmacies
Figure 57 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Retail Pharmacies
Figure 58 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Retail Pharmacies
Figure 59 : Latin America Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Mail Order Pharmacies
Figure 60 : Latin America Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Mail Order Pharmacies
Figure 61 : Latin America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Drug Type
Figure 62 : Latin America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Route of Administration
Figure 63 : Latin America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Distribution Channel
Figure 64 : Latin America Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Country
Figure 65 : Europe Clostridium Difficile Infection Treatment Market Value Share By Drug Type  (2017)
Figure 66 : Europe Clostridium Difficile Infection Treatment Market Value Share By Route of Administration (2017)
Figure 67 : Europe Clostridium Difficile Infection Treatment Market Value Share By Distribution Channel (2017)
Figure 68 : Europe Clostridium Difficile Infection Treatment Market Value Share By Country  (2017)
Figure 69 : Europe Clostridium Difficile Infection Treatment Market Forecast 2017 and 2025
Figure 70 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016
Figure 71 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 72 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Metronidazole
Figure 73 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Metronidazole
Figure 74 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Vancomycin
Figure 75 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Vancomycin
Figure 76 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Fidaxomicin 
Figure 77 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Fidaxomicin 
Figure 78 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Oral
Figure 79 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Oral
Figure 80 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Injectable
Figure 81 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Injectable
Figure 82 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Hospital Pharmacies
Figure 83 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Hospital Pharmacies
Figure 84 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Retail Pharmacies
Figure 85 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Retail Pharmacies
Figure 86 : Europe Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Mail Order Pharmacies
Figure 87 : Europe Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Mail Order Pharmacies
Figure 88 : Europe Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Drug Type
Figure 89 : Europe Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Route of Administration
Figure 90 : Europe Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Distribution Channel
Figure 91 : Europe Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Country
Figure 92 : Asia Pacific Clostridium Difficile Infection Treatment Market Value Share By Drug Type  (2017)
Figure 93 : Asia Pacific Clostridium Difficile Infection Treatment Market Value Share By Route of Administration (2017)
Figure 94 : Asia Pacific Clostridium Difficile Infection Treatment Market Value Share By Distribution Channel (2017)
Figure 95 : Asia Pacific Clostridium Difficile Infection Treatment Market Value Share By Country  (2017)
Figure 96 : Asia Pacific Clostridium Difficile Infection Treatment Market Forecast 2017 and 2025
Figure 97 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016
Figure 98 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 99 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Metronidazole
Figure 100 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Metronidazole
Figure 101 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Vancomycin
Figure 102 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Vancomycin
Figure 103 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Fidaxomicin 
Figure 104 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Fidaxomicin 
Figure 105 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Oral
Figure 106 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Oral
Figure 107 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Injectable
Figure 108 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Injectable
Figure 109 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Hospital Pharmacies
Figure 110 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Hospital Pharmacies
Figure 111 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Retail Pharmacies
Figure 112 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Retail Pharmacies
Figure 113 : Asia Pacific Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Mail Order Pharmacies
Figure 114 : Asia Pacific Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Mail Order Pharmacies
Figure 115 : Asia Pacific Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Drug Type
Figure 116 : Asia Pacific Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Route of Administration
Figure 117 : Asia Pacific Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Distribution Channel
Figure 118 : Asia Pacific Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Country
Figure 119  : MEA Clostridium Difficile Infection Treatment Market Value Share By Drug Type  (2017)
Figure 120 : MEA Clostridium Difficile Infection Treatment Market Value Share By Route of Administration (2017)
Figure 121 : MEA Clostridium Difficile Infection Treatment Market Value Share By Distribution Channel (2017)
Figure 122 : MEA Clostridium Difficile Infection Treatment Market Value Share By Country  (2017)
Figure 123 : MEA Clostridium Difficile Infection Treatment Market Forecast 2017 and 2025
Figure 124 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016
Figure 125  : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 126 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Metronidazole
Figure 127 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Metronidazole
Figure 128 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Vancomycin
Figure 129 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Vancomycin
Figure 130 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Fidaxomicin 
Figure 131 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Fidaxomicin 
Figure 132 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Oral
Figure 133 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Oral
Figure 134 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Injectable
Figure 135 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Injectable
Figure 136 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Hospital Pharmacies
Figure 137 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Hospital Pharmacies
Figure 138 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Retail Pharmacies
Figure 139 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Retail Pharmacies
Figure 140 : MEA Clostridium Difficile Infection Treatment Market Size Analysis, 2012–2016, By Mail Order Pharmacies
Figure 141 : MEA Clostridium Difficile Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Mail Order Pharmacies
Figure 142 : MEA Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Drug Type
Figure 143 : MEA Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Route of Administration
Figure 144 : MEA Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Distribution Channel
Figure 145 : MEA Clostridium Difficile Infection Treatment Market Attractiveness Analysis, 2017–2025, By Country
Figure 146 : Global Clostridium Difficile Infection Treatment Market Attractiveness Analysis By Region, 2017–2025
Figure 147 : Global Clostridium Difficile Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2025
Figure 148 : Global Clostridium Difficile Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2025
Figure 149 : Global Clostridium Difficile Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 150 : Global Clostridium Difficile Infection Treatment Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 151 : Global Clostridium Difficile Infection Treatment Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 152 : Global Clostridium Difficile Infection Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2025